Integrated facilities management for a multinational pharmaceuticals company

Challenges:

• Faced with the global acquisition of a pharmaceutical company, the real estate team at client side needed help to meet their value capture targets fast. The Company engaged JLL to help rationalise consolidation efforts for their Ex-U.S. portfolio and to realise their goals in a quick time frame

• JLL assisted the team in developing a portfolio consolidation and integration plan involving 55 different markets internationally and over 160 properties, 12M sq. ft. and $330M in annual occupancy costs

Solution & value creation:

• Established integration management protocols to ensure discreet management of confidential strategic initiatives

• Baselined, validated and confirmed the current supply and demand of the combined portfolio resulting in a master database for the combined organisation

• Filtered over 600 assets in more than 100 markets to drive value capture towards the $75M ex-U.S. synergy target

• Vetted market conditions at the asset level with the JLL international brokerage network to confirm and substantiate strategies

• Integrated workplace strategies to accommodate progressive work styles and drive broader efficiencies in the portfolio

• Evaluated over 100 regional scenarios to ensure optimal line-of-business buy-in (what works, what doesn’t work)

• Presented findings and recommendations to regional business leads and executive committee for execution

• Created an integrated execution framework to address complex nuances such as works’ councils, logistics, move management, and attrition associated with post-merger integration

Results:

• Results led to consolidation plans which identified between $54M and $83M in annual cost savings and will meet their value capture goal between 34% and 52% for the Ex-US portfolio

• All of our recommendations were accepted by the Company’s executive committee without exception and have been implemented